Enoblituzumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Enoblituzumab, covering 2022-02-08 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer [Phase 2]